In animal models of PD, administering IL-1 receptor antagonists significantly reduced TNF-α and interferon gamma (IFN-γ), decreasing the elevated loss of dopaminergic neurons induced by LPS [115]. This evidence concerns the gene IFNG and Parkinson disease.